Your browser doesn't support javascript.
loading
Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors.
Temido-Ferreira, Mariana; Ferreira, Diana G; Batalha, Vânia L; Marques-Morgado, Inês; Coelho, Joana E; Pereira, Pedro; Gomes, Rui; Pinto, Andreia; Carvalho, Sara; Canas, Paula M; Cuvelier, Laetitia; Buée-Scherrer, Valerie; Faivre, Emilie; Baqi, Younis; Müller, Christa E; Pimentel, José; Schiffmann, Serge N; Buée, Luc; Bader, Michael; Outeiro, Tiago F; Blum, David; Cunha, Rodrigo A; Marie, Hélène; Pousinha, Paula A; Lopes, Luísa V.
Afiliação
  • Temido-Ferreira M; Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Universidade de Lisboa, 1649-028, Lisbon, Portugal.
  • Ferreira DG; Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Universidade de Lisboa, 1649-028, Lisbon, Portugal.
  • Batalha VL; Department of Experimental Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, Center for Biostructural Imaging of Neurodegeneration, University Medical Center Göttingen, Waldweg 33, 37073, Göttingen, Germany.
  • Marques-Morgado I; Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Coelho JE; MedInUP-Center for Drug Discovery and Innovative Medicines, University of Porto, 4200-450, Porto, Portugal.
  • Pereira P; Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Universidade de Lisboa, 1649-028, Lisbon, Portugal.
  • Gomes R; Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Universidade de Lisboa, 1649-028, Lisbon, Portugal.
  • Pinto A; Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Universidade de Lisboa, 1649-028, Lisbon, Portugal.
  • Carvalho S; Laboratory of Neuropathology, Department of Neurosciences, Hospital de Santa Maria, CHLN, EPE, 1649-035, Lisbon, Portugal.
  • Canas PM; Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Universidade de Lisboa, 1649-028, Lisbon, Portugal.
  • Cuvelier L; Faculdade de Ciências da Universidade de Lisboa, 1749-016, Lisbon, Portugal.
  • Buée-Scherrer V; Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Universidade de Lisboa, 1649-028, Lisbon, Portugal.
  • Faivre E; Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Universidade de Lisboa, 1649-028, Lisbon, Portugal.
  • Baqi Y; CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504, Coimbra, Portugal.
  • Müller CE; Faculty of Medicine, University of Coimbra, 3004-504, Coimbra, Portugal.
  • Pimentel J; Laboratory of Neurophysiology, ULB Neuroscience Institute, Université Libre de Bruxelles (ULB), 1070, Brussels, Belgium.
  • Schiffmann SN; Université de Lille, Institut National de la Santé et de la Recherche Medicale (INSERM), CHU Lille, UMR-S 1172 JPArc, "Alzheimer & Tauopathie", LabEx DISTALZ, Lille, France.
  • Buée L; Université de Lille, Institut National de la Santé et de la Recherche Medicale (INSERM), CHU Lille, UMR-S 1172 JPArc, "Alzheimer & Tauopathie", LabEx DISTALZ, Lille, France.
  • Bader M; PharmaCenter Bonn, Pharmazeutische Chemie I, Pharmazeutisches Institut, University of Bonn, Bonn, Germany.
  • Outeiro TF; Department of Chemistry, Faculty of Science, Sultan Qaboos University, PO Box 36, Postal Code 123, Muscat, Oman.
  • Blum D; PharmaCenter Bonn, Pharmazeutische Chemie I, Pharmazeutisches Institut, University of Bonn, Bonn, Germany.
  • Cunha RA; Laboratory of Neuropathology, Department of Neurosciences, Hospital de Santa Maria, CHLN, EPE, 1649-035, Lisbon, Portugal.
  • Marie H; Laboratory of Neurophysiology, ULB Neuroscience Institute, Université Libre de Bruxelles (ULB), 1070, Brussels, Belgium.
  • Pousinha PA; Université de Lille, Institut National de la Santé et de la Recherche Medicale (INSERM), CHU Lille, UMR-S 1172 JPArc, "Alzheimer & Tauopathie", LabEx DISTALZ, Lille, France.
  • Lopes LV; Max-Delbrück-Center for Molecular Medicine (MDC), 13125, Berlin, Germany.
Mol Psychiatry ; 25(8): 1876-1900, 2020 08.
Article em En | MEDLINE | ID: mdl-29950682
ABSTRACT
Synaptic dysfunction plays a central role in Alzheimer's disease (AD), since it drives the cognitive decline. An association between a polymorphism of the adenosine A2A receptor (A2AR) encoding gene-ADORA2A, and hippocampal volume in AD patients was recently described. In this study, we explore the synaptic function of A2AR in age-related conditions. We report, for the first time, a significant overexpression of A2AR in hippocampal neurons of aged humans, which is aggravated in AD patients. A similar profile of A2AR overexpression in rats was sufficient to drive age-like memory impairments in young animals and to uncover a hippocampal LTD-to-LTP shift. This was accompanied by increased NMDA receptor gating, dependent on mGluR5 and linked to enhanced Ca2+ influx. We confirmed the same plasticity shift in memory-impaired aged rats and APP/PS1 mice modeling AD, which was rescued upon A2AR blockade. This A2AR/mGluR5/NMDAR interaction might prove a suitable alternative for regulating aberrant mGluR5/NMDAR signaling in AD without disrupting their constitutive activity.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Envelhecimento / Receptores de N-Metil-D-Aspartato / Depressão Sináptica de Longo Prazo / Receptor A2A de Adenosina / Receptor de Glutamato Metabotrópico 5 / Neurônios Limite: Animals / Humans Idioma: En Revista: Mol Psychiatry Assunto da revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Portugal

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Envelhecimento / Receptores de N-Metil-D-Aspartato / Depressão Sináptica de Longo Prazo / Receptor A2A de Adenosina / Receptor de Glutamato Metabotrópico 5 / Neurônios Limite: Animals / Humans Idioma: En Revista: Mol Psychiatry Assunto da revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Portugal